Market Trends of China Diagnostic Imaging Industry
This section covers the major market trends shaping the China Diagnostic Imaging Market according to our research experts:
Oncology Segment is Expected to Hold a Major Market Share in the China Diagnostic Imaging Market
Cancer incidence and mortality have been increasing in China for a long time, thus making it the leading cause of death in this country. As per an article titled 'Comparison of cancer incidence and mortality between China and the United States' published in December 2021, in 2020, there are 4.6 million new cases in China and the Age-standardized mortality rate (ASMR) of cancer in China is 129.4 per 100,000.
Similarly, according to an article titled 'Cancer statistics in China and United States, 2022: profiles, trends, and determinants' published in February 2022, it is expected that approximately 4,820,000 people are expected to have newly diagnosed with cancer, and 3,210,000 people dying from cancer in China in 2022.
Furthermore, China is attempting to address its steadily rising cancer burden. However, it faces numerous new obstacles to cancer prevention due to the rising aging of the population and the cumulative impact of risk factor exposure. Cancer profiles, trends, and factors in China and the USA could be compared to help China with its cancer preventive initiatives and policymaking.
The rising burden is also attributable to population growth and aging and socio-demographic changes. Hence the rising prevalence of various types of cancer in China and the increasing need for cost-effective diagnosis using advanced cancer imaging techniques are expected to drive the market.
